EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.1.B29 | recombinant expression of His-tagged E140 mutants of mevalonate 3-kinase, functioning as 5-phosphomevalonate 3-kinases, in Escherichia coli strain BL21 | Thermoplasma acidophilum |
2.7.1.185 | gene Ta1305, the pBAD-TacM plasmid series contains the genes of M3K, M3P5K, BMD, and IPK for the expression of part of modified MVA pathway II. Although the M3K, M3P5K, and IPK genes are derived from Thermoplasma acidophilum, various BMD genes have been utilized for plasmid construction. Recombinant expression of His-tagged enzyme in Escherichia coli strain BL21 | Thermoplasma acidophilum |
2.7.1.186 | gene Ta0762, the pBAD-TacM plasmid series contains the genes of M3K, M3P5K, BMD, and IPK for the expression of part of modified MVA pathway II. Although the M3K, M3P5K, and IPK genes are derived from Thermoplasma acidophilum, various BMD genes have been utilized for plasmid construction. Recombinant expression of His-tagged enzyme in Escherichia coli strain BL21 | Thermoplasma acidophilum |
2.7.4.2 | gene ERG8, the pBAD plasmid containing the genes of MVK, PMK, and DMD from Saccharomyces cerevisiae (pBAD-ScMPD) is used for expression of a part of the classical MVA pathway (Fig. 6B). The codon usage of the MVK and PMK genes has been optimized for Escherichia coli, recombinant expression of His-tagged enzyme in Escherichia coli strain BL21 | Saccharomyces cerevisiae |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
2.7.1.185 | analysis of the substrate-complex crystal structure of TacM3K (PDB ID 4RKS) | Thermoplasma acidophilum |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.7.1.B29 | additional information | substrate-interacting glutamate residue E140 of Thermoplasma acidophilum mevalonate 3-kinase (EC 2.7.1.185) is replaced by smaller amino acids, including its counterparts in diphosphomevalonate decarboxylase and phosphomevalonate decarboxylase, with the aim of altering substrate specificity. These single amino acid mutations results in the conversion of mevalonate 3-kinase into 5-phosphomevalonate 3-kinase, which can synthesize 3,5-bisphosphomevalonate from 5-phosphomevalonate. The mutants catalyzing the hitherto undiscovered reaction enables the construction of an artificial mevalonate pathway in Escherichia coli cells, as is demonstrated by the accumulation of lycopene, a red carotenoid pigment. Alternative MVA pathway II overview. Constructed plasmids and strains, overview | Thermoplasma acidophilum |
2.7.1.185 | E140A | site-directed mutagenesis, inactive mutant | Thermoplasma acidophilum |
2.7.1.185 | E140G | site-directed mutagenesis, the mutation results in the conversion of mevalonate 3-kinase into 5-phosphomevalonate 3-kinase, which can synthesize 3,5-bisphosphomevalonate from 5-phosphomevalonate | Thermoplasma acidophilum |
2.7.1.185 | E140S | site-directed mutagenesis, the mutation results in the conversion of mevalonate 3-kinase into 5-phosphomevalonate 3-kinase, which can synthesize 3,5-bisphosphomevalonate from 5-phosphomevalonate | Thermoplasma acidophilum |
2.7.1.185 | additional information | substrate-interacting glutamate residue E140 of Thermoplasma acidophilum mevalonate 3-kinase is replaced by smaller amino acids, including its counterparts in diphosphomevalonate decarboxylase and phosphomevalonate decarboxylase, with the aim of altering substrate specificity. These single amino acid mutations results in the conversion of mevalonate 3-kinase into 5-phosphomevalonate 3-kinase, which can synthesize 3,5-bisphosphomevalonate from 5-phosphomevalonate. The mutants catalyzing the hitherto undiscovered reaction enables the construction of an artificial mevalonate pathway in Escherichia coli cells, as is demonstrated by the accumulation of lycopene, a red carotenoid pigment. Neither wild-type TacM3K nor any mutants show reactivity toward MVA 5-diphosphate. Alternative MVA pathway II overview. Constructed plasmids and strains, overview | Thermoplasma acidophilum |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | Thermoplasma acidophilum | - |
ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | Thermoplasma acidophilum JCM 9062 | - |
ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | Thermoplasma acidophilum AMRC-C165 | - |
ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | Thermoplasma acidophilum ATCC 25905 | - |
ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | Thermoplasma acidophilum NBRC 15155 | - |
ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | Thermoplasma acidophilum | - |
ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | Thermoplasma acidophilum JCM 9062 | - |
ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | Thermoplasma acidophilum AMRC-C165 | - |
ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | Thermoplasma acidophilum ATCC 25905 | - |
ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | Thermoplasma acidophilum NBRC 15155 | - |
ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | Thermoplasma acidophilum | - |
ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | Thermoplasma acidophilum JCM 9062 | - |
ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | Thermoplasma acidophilum AMRC-C165 | - |
ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | Thermoplasma acidophilum ATCC 25905 | - |
ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | Thermoplasma acidophilum NBRC 15155 | - |
ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.4.2 | ATP + (R)-5-phosphomevalonate | Saccharomyces cerevisiae | - |
ADP + (R)-5-diphosphomevalonate | - |
? | |
2.7.4.2 | ATP + (R)-5-phosphomevalonate | Saccharomyces cerevisiae ATCC 204508 | - |
ADP + (R)-5-diphosphomevalonate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.B29 | Thermoplasma acidophilum | - |
- |
- |
2.7.1.B29 | Thermoplasma acidophilum AMRC-C165 | - |
- |
- |
2.7.1.B29 | Thermoplasma acidophilum ATCC 25905 | - |
- |
- |
2.7.1.B29 | Thermoplasma acidophilum JCM 9062 | - |
- |
- |
2.7.1.B29 | Thermoplasma acidophilum NBRC 15155 | - |
- |
- |
2.7.1.185 | Thermoplasma acidophilum | Q9HIN1 | - |
- |
2.7.1.185 | Thermoplasma acidophilum AMRC-C165 | Q9HIN1 | - |
- |
2.7.1.185 | Thermoplasma acidophilum ATCC 25905 | Q9HIN1 | - |
- |
2.7.1.185 | Thermoplasma acidophilum JCM 9062 | Q9HIN1 | - |
- |
2.7.1.185 | Thermoplasma acidophilum NBRC 15155 | Q9HIN1 | - |
- |
2.7.1.186 | Thermoplasma acidophilum | Q9HK44 | - |
- |
2.7.1.186 | Thermoplasma acidophilum AMRC-C165 | Q9HK44 | - |
- |
2.7.1.186 | Thermoplasma acidophilum ATCC 25905 | Q9HK44 | - |
- |
2.7.1.186 | Thermoplasma acidophilum JCM 9062 | Q9HK44 | - |
- |
2.7.1.186 | Thermoplasma acidophilum NBRC 15155 | Q9HK44 | - |
- |
2.7.4.2 | Saccharomyces cerevisiae | P24521 | - |
- |
2.7.4.2 | Saccharomyces cerevisiae ATCC 204508 | P24521 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.7.1.B29 | recombinant His-tagged enzymes from Escherichia coli strain BL21 by nickel affinity chromatography | Thermoplasma acidophilum |
2.7.1.185 | recombinant His-tagged enzyme from Escherichia coli strain BL21 by nickel affinity chromatography | Thermoplasma acidophilum |
2.7.1.186 | recombinant His-tagged enzyme from Escherichia coli strain BL21 by nickel affinity chromatography | Thermoplasma acidophilum |
2.7.4.2 | recombinant His-tagged enzyme from Escherichia coli strain BL21 by nickel affinity chromatography | Saccharomyces cerevisiae |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | - |
Thermoplasma acidophilum | ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | - |
Thermoplasma acidophilum JCM 9062 | ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | - |
Thermoplasma acidophilum AMRC-C165 | ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | - |
Thermoplasma acidophilum ATCC 25905 | ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | ATP + (R)-5-phosphomevalonate | - |
Thermoplasma acidophilum NBRC 15155 | ADP + (R)-3,5-bisphosphomevalonate | - |
? | |
2.7.1.B29 | additional information | substrate specificity analysis, no reactivity toward MVA 5-diphosphate. Electrospray ionization mass spectrometry (ESI-MS) analysis of the product is performed in the negative mode using the direct infusion method | Thermoplasma acidophilum | ? | - |
- |
|
2.7.1.B29 | additional information | substrate specificity analysis, no reactivity toward MVA 5-diphosphate. Electrospray ionization mass spectrometry (ESI-MS) analysis of the product is performed in the negative mode using the direct infusion method | Thermoplasma acidophilum JCM 9062 | ? | - |
- |
|
2.7.1.B29 | additional information | substrate specificity analysis, no reactivity toward MVA 5-diphosphate. Electrospray ionization mass spectrometry (ESI-MS) analysis of the product is performed in the negative mode using the direct infusion method | Thermoplasma acidophilum AMRC-C165 | ? | - |
- |
|
2.7.1.B29 | additional information | substrate specificity analysis, no reactivity toward MVA 5-diphosphate. Electrospray ionization mass spectrometry (ESI-MS) analysis of the product is performed in the negative mode using the direct infusion method | Thermoplasma acidophilum ATCC 25905 | ? | - |
- |
|
2.7.1.B29 | additional information | substrate specificity analysis, no reactivity toward MVA 5-diphosphate. Electrospray ionization mass spectrometry (ESI-MS) analysis of the product is performed in the negative mode using the direct infusion method | Thermoplasma acidophilum NBRC 15155 | ? | - |
- |
|
2.7.1.185 | ATP + (R)-mevalonate | - |
Thermoplasma acidophilum | ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | - |
Thermoplasma acidophilum JCM 9062 | ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | - |
Thermoplasma acidophilum AMRC-C165 | ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | - |
Thermoplasma acidophilum ATCC 25905 | ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | ATP + (R)-mevalonate | - |
Thermoplasma acidophilum NBRC 15155 | ADP + (R)-3-phosphomevalonate | - |
? | |
2.7.1.185 | additional information | substrate specificity, overview | Thermoplasma acidophilum | ? | - |
- |
|
2.7.1.185 | additional information | substrate specificity, overview | Thermoplasma acidophilum JCM 9062 | ? | - |
- |
|
2.7.1.185 | additional information | substrate specificity, overview | Thermoplasma acidophilum AMRC-C165 | ? | - |
- |
|
2.7.1.185 | additional information | substrate specificity, overview | Thermoplasma acidophilum ATCC 25905 | ? | - |
- |
|
2.7.1.185 | additional information | substrate specificity, overview | Thermoplasma acidophilum NBRC 15155 | ? | - |
- |
|
2.7.1.186 | ATP + (R)-3-phosphomevalonate | - |
Thermoplasma acidophilum | ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | - |
Thermoplasma acidophilum JCM 9062 | ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | - |
Thermoplasma acidophilum AMRC-C165 | ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | - |
Thermoplasma acidophilum ATCC 25905 | ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.1.186 | ATP + (R)-3-phosphomevalonate | - |
Thermoplasma acidophilum NBRC 15155 | ADP + 3,5-bisphosphomevalonate | - |
? | |
2.7.4.2 | ATP + (R)-5-phosphomevalonate | - |
Saccharomyces cerevisiae | ADP + (R)-5-diphosphomevalonate | - |
? | |
2.7.4.2 | ATP + (R)-5-phosphomevalonate | - |
Saccharomyces cerevisiae ATCC 204508 | ADP + (R)-5-diphosphomevalonate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.1.185 | M3K | - |
Thermoplasma acidophilum |
2.7.1.185 | mevalonate 3-kinase | - |
Thermoplasma acidophilum |
2.7.1.185 | Ta1305 | - |
Thermoplasma acidophilum |
2.7.1.185 | TacM3K | - |
Thermoplasma acidophilum |
2.7.1.186 | M3P5K | - |
Thermoplasma acidophilum |
2.7.1.186 | MVA-3-P 5-kinase | - |
Thermoplasma acidophilum |
2.7.1.186 | Ta0762 | - |
Thermoplasma acidophilum |
2.7.4.2 | ERG8 | - |
Saccharomyces cerevisiae |
2.7.4.2 | PMK | - |
Saccharomyces cerevisiae |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.1.B29 | physiological function | a substrate-interacting glutamate residue of Thermoplasma acidophilum mevalonate 3-kinase (EC 2.7.1.185) is replaced by smaller amino acids, including its counterparts in diphosphomevalonate decarboxylase and phosphomevalonate decarboxylase, with the aim of altering substrate specificity. These single amino acid mutations E140S and E140G result in the conversion of mevalonate 3-kinase into 5-phosphomevalonate 3-kinase, which can synthesize 3,5-bisphosphomevalonate from 5-phosphomevalonate. The mutants catalyzing the hitherto undiscovered reaction enables the construction of an artificial mevalonate pathway in Escherichia coli cells, as is demonstrated by the accumulation of lycopene, a red carotenoid pigment | Thermoplasma acidophilum |
2.7.1.185 | evolution | mevalonate 3-kinase is an enzyme involved in the modified mevalonate pathway specific to limited species of thermophilic archaea | Thermoplasma acidophilum |
2.7.1.185 | metabolism | mevalonate 3-kinase plays a key role in a recently discovered modified mevalonate pathway specific to thermophilic archaea of the order Thermoplasmatales, pathway overview. In the pathway called modified MVA pathway II, mevalonate (MVA) is phosphorylated at the 3-hydroxyl group to yield 3-phosphomevalonate (MVA-3-P) by the action of mevalonate 3-kinase (M3K) rather than at the 5-hydroxyl group as in the reaction of MVK (EC 2.7.4.2). M3K is also homologous to diphosphomevalonate decarboxylase (DMD, EC 4.1.1.33). After the formation of MVA-3-P, another kinase, MVA-3-P 5-kinase (M3P5K), catalyzes its 5-phosphorylation, and a subsequent decarboxylation is catalyzed by another DMD homologue, 3,5-bisphosphomevalonate decarboxylase (BMD), to give isopentenyl phosphate (IP). IP is then phosphorylated by isopentenyl phosphate kinase (IPK) to yield isopentenyl diphosphate (IPP). The M3K enzyme is homologous to diphosphomevalonate decarboxylase, which is involved in the widely distributed classical mevalonate pathway, and to phosphomevalonate decarboxylase, which is possessed by halophilic archaea and some Chloroflexi bacteria. Neither wild-type TacM3K nor any mutants show reactivity toward MVA 5-diphosphate | Thermoplasma acidophilum |
2.7.1.185 | additional information | comparison between the substrate-complex crystal structure of TacM3K (PDB ID 4RKS) and that of Sulfolobus solfataricus DMD (SsoDMD, PDB ID 5GMD) revealing interesting differences in the structures of the active sites. The steric hindrance introduced by Glu140 seems responsible for excluding larger substrates, such as MVA 5-phosphate and MVA 5-diphosphate, from the active site of TacM3K | Thermoplasma acidophilum |
2.7.1.185 | physiological function | mevalonate 3-kinase catalyzes the ATP-dependent 3-phosphorylation of mevalonate but does not catalyze the subsequent decarboxylation as related decarboxylases do | Thermoplasma acidophilum |
2.7.1.186 | evolution | mevalonate 3-phosphate 5-kinase is an enzyme involved in the modified mevalonate pathway specific to limited species of thermophilic archaea | Thermoplasma acidophilum |
2.7.1.186 | metabolism | mevalonate 3-kinase plays a key role in a recently discovered modified mevalonate pathway specific to thermophilic archaea of the order Thermoplasmatales, pathway overview. In the pathway called modified MVA pathway II, mevalonate (MVA) is phosphorylated at the 3-hydroxyl group to yield 3-phosphomevalonate (MVA-3-P) by the action of mevalonate 3-kinase (M3K, EC 2.7.1.185) rather than at the 5-hydroxyl group as in the reaction of MVK (EC 2.7.4.2). M3K is also homologous to diphosphomevalonate decarboxylase (DMD). After the formation of MVA-3-P, another kinase, MVA-3-P 5-kinase (M3P5K), catalyzes its 5-phosphorylation, and a subsequent decarboxylation is catalyzed by another DMD homologue, 3,5-bisphosphomevalonate decarboxylase (BMD), to give isopentenyl phosphate (IP). IP is then phosphorylated by isopentenyl phosphate kinase (IPK) to yield isopentenyl diphosphate (IPP) | Thermoplasma acidophilum |
2.7.1.186 | physiological function | mevalonate 3-phosphate 5-kinase catalyzes the ATP-dependent 5-phosphorylation of 3-phosphomevalonate | Thermoplasma acidophilum |
2.7.4.2 | metabolism | almost all eukaryotes, most of the MVA pathway-utilizing bacteria, and the archaea of the order Sulfolobales utilize mevalonate kinase (MVK), phosphomevalonate kinase (PMK), and diphosphomevalonate decarboxylase (DMD) for that purpose. The pathway that includes this set of enzymes is called the classical MVA pathway because it was discovered more than half a century ago | Saccharomyces cerevisiae |
2.7.4.2 | physiological function | mevalonate 3-kinase catalyzes the ATP-dependent 3-phosphorylation of mevalonate but does not catalyze the subsequent decarboxylation as related decarboxylases do | Saccharomyces cerevisiae |